SEVMALrisk: an externally verified clinical risk score for an early risk rating for severe entry of
An international medical study has yielded new findings that are of important reference value for disease prevention and control. Early identification of severe entry malaria is essential because treatment decisions often need to be made before reliable parasite density measurements are available. During this time, Objective tools to support early risk scales have been developed and external verification of the lack of SEVMALrisk, an explanatory clinical risk score for the development of admissible laboratory parameters.
The best-performing model was optimized using SHapley Additive exPlanations (SHAP) for interpretation and translation using SEVMALrisk clinical risk score for translation. Independent external verification was carried out on multi-center arrays (n = 124). The optimized prediction model has an area of 0.
962 W under the receiving operating characteristic curve (AUROC). It should be noted that the above information is based on the results of international public research and is for reference in HealthCop and does not constitute clinical advice.
